Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. G. (Gert) Luurtsema

Research interests

The research of Gert Luurtsema, associate professor at the UMCG, is focused on a broad range of topics, ranging from tracer development to validation of clinical imaging applications. With support of NWO-STW funding, he has accomplished a research line on imaging of the blood-brain barrier (BBB) integrity in relation to brain disorders and drug delivery. Besides this, he is supervising > 7 PhD students, 5 master students and 3 postdocs. Currently, he is (co-)author of more than 100 peer-reviewed scientific articles in high ranking journals and scientific textbooks. He was guest editor of the journals Current Pharmaceutical Design and Contrast Media & Molecular Imaging. 

Publicaties

One-pot synthesis of 6-l-[18f] fluoro-3,4-dihydroxyphenylalanine (6-l-[18f] fdopa).

[15O]H2O PET: Potential or Essential for Molecular Imaging?

Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and Challenges

Effects of proton therapy on regional [18F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancer

Non-invasive kinetic modelling approaches for quantitative analysis of brain PET studies

Oral administration of PET tracers: Current status

Quantification of P-glycoprotein function at the human blood-brain barrier using [ 18F]MC225 and PET.

Severely increased albuminuria in patients with type 2 diabetes mellitus is associated with increased subclinical atherosclerosis in femoral arteries with Na [<sup>18</sup>F]F activity as a proxy - The DETERMINE study

Severely increased albuminuria in patients with type 2 diabetes mellitus is associated with increased subclinical atherosclerosis in femoral arteries with Na [18F]F activity as a proxy: The DETERMINE study

A proof-of-concept study on the use of a fluorescein-based 18F-tracer for pretargeted PET

Lees meer

Pers/media

Diagnosi di malattie cerebrali oggi se ne parla a Triggiano

Diagnose van prostaatkanker bij Treant op topniveau